Boston Trust Walden Corp Axcelis Technologies Inc Transaction History
Boston Trust Walden Corp
- $13.4 Billion
- Q3 2025
A detailed history of Boston Trust Walden Corp transactions in Axcelis Technologies Inc stock. As of the latest transaction made, Boston Trust Walden Corp holds 460,287 shares of ACLS stock, worth $37.7 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
460,287
Previous 845,911
45.59%
Holding current value
$37.7 Million
Previous $59 Million
23.76%
% of portfolio
0.34%
Previous 0.43%
Shares
5 transactions
Others Institutions Holding ACLS
# of Institutions
383Shares Held
31.7MCall Options Held
436KPut Options Held
418K-
Black Rock Inc. New York, NY5.81MShares$475 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.32MShares$354 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.66MShares$136 Million0.07% of portfolio
-
Reinhart Partners, Inc.1.61MShares$132 Million5.4% of portfolio
-
State Street Corp Boston, MA1.25MShares$102 Million0.0% of portfolio
About AXCELIS TECHNOLOGIES INC
- Ticker ACLS
- Exchange NASDAQ
- Sector Technology
- Industry Semiconductor Equipment & Materials
- Shares Outstandng 33,033,800
- Market Cap $2.7B
- Description
- Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecy...